| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Agios Pharmaceuticals, Inc.(AGIO) | 2,978,134 | $200.8M | 42.76% |
| 2 | Alnylam Pharmaceuticals, Inc.(ALNY) | 1,631,089 | $152.4M | 32.45% |
| 3 | Argenx SE(ARGX) | 904,739 | $112.9M | 24.05% |
| 4 | Ionis Pharmaceuticals Inc.(IONS) | 7,725,000 | $627.0K | 0.13% |
| 5 | Incyte Corp.(INCY) | 3,620,000 | $311.4K | 0.07% |
| 6 | Neurocrine Biosciences Inc.(NBIX) | 3,366,786 | $296.6K | 0.06% |
| 7 | Vertex Pharmaceuticals Inc(VRTX) | 1,300,000 | $239.1K | 0.05% |
| 8 | Sage Therapeutics, Inc.(SG7) | 1,375,229 | $218.7K | 0.05% |
| 9 | Celgene Corp(CELG) | 2,200,000 | $207.5K | 0.04% |
| 10 | Alexion Pharmaceuticals, Inc.(ALXN) | 1,314,428 | $177.7K | 0.04% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 99.71% | 99.71% | 0% |
| Unclassified | 0.29% | 0.29% | 0% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Large Cap | 59.98% | 56.86% | -3.12% |
| Small Cap | 39.65% | 42.79% | +3.14% |
| Unclassified | 0.29% | 0.29% | 0% |
| Micro Cap | 0.03% | 0.03% | 0% |
| Mid Cap | 0.05% | 0.03% | -0.02% |
Quarter-over-quarter position changes